Abstract
Very/extremely premature infants often experience glycaemic dysregulation, resulting in abnormally elevated (hyperglycaemia) or low (hypoglycaemia) blood glucose (BG) concentrations, due to prematurity, stress, and illness. STAR-GRYPHON is a computerised protocol that utilises a model-based insulin sensitivity parameter to directly tailor therapy for individual patients and their changing conditions, unlike other common insulin protocols in this cohort. From January 2013 to January 2015, 13 patients totalling 16 hyperglycaemic control episodes received insulin under STAR-GRYPHON. A significant improvement in control was achieved in comparison to a retrospective cohort, with a 26% absolute improvement in BG within the targeted range and no hypoglycaemia. This improvement was obtained predominantly due to the reduction of hyperglycaemia (%BG>10.0 mmol/l: 5.6 vs. 17.7%, p<0.001), and lowering of the median per-patient BG [6.9 (6.1–7.9) vs. 7.8 (6.6–9.1) mmol/l, p<0.001, Mann-Witney U test]. While cohort-wide control results show good control overall, there is high intra-patient variability in BG behaviour, resulting in overly conservative treatments for some patients. Patient insulin sensitivity differs between and within patients over time, with some patients having stable insulin sensitivity, while others change rapidly. These results demonstrate the trade-off between safety and performance in a highly variable and fragile cohort.
Acknowledgments and conflicts of interest
The authors declare that they have no conflicts of interests. Funding was provided from HRSC grants (Christchurch, New Zealand) and post-graduate study grants from the University of Canterbury.
References
[1] Alaedeen DI, Walsh MC, Chwals WJ. Total parenteral nutrition-associated hyperglycemia correlates with prolonged mechanical ventilation and hospital stay in septic infants. J Pediatr Surg 2006; 41: 239–244.10.1016/j.jpedsurg.2005.10.045Search in Google Scholar
[2] Alsweiler JM, Harding JE, Bloomfield FH. Tight glycemic control with insulin in hyperglycemic preterm babies: a randomized controlled trial. Pediatrics 2012; 129: 639–647.10.1542/peds.2011-2470Search in Google Scholar
[3] Alsweiler JM, Kuschel CA, Bloomfield FH. Survey of the management of neonatal hyperglycaemia in Australasia. J Paediatr Child Health 2007; 43: 632–635.10.1111/j.1440-1754.2007.01158.xSearch in Google Scholar
[4] Beardsall K, Ogilvy-Stuart AL, Ahluwalia J, Thompson M, Dunger DB. The continuous glucose monitoring sensor in neonatal intensive care. Arch Dis Child Fetal Neonatal Ed 2005; 90: F307–F310.10.1136/adc.2004.051979Search in Google Scholar
[5] Beardsall K, Vanhaesebrouck S, Ogilvy-Stuart AL, et al. Early insulin therapy in very-low-birth-weight infants. N Engl J Med 2008; 359: 1873–1884.10.1056/NEJMoa0803725Search in Google Scholar
[6] Binder ND, Raschko PK, Benda GI, Reynolds JW. Insulin infusion with parenteral nutrition in extremely low birth weight infants with hyperglycemia. J Pediatr 1989; 114: 273–280.10.1016/S0022-3476(89)80797-8Search in Google Scholar
[7] Blanco CL, Baillargeon JG, Morrison RL, Gong AK. Hyperglycemia in extremely low birth weight infants in a predominantly Hispanic population and related morbidities. J Perinatol 2006; 26: 737–741.10.1038/sj.jp.7211594Search in Google Scholar
[8] Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000; 355: 773–778.10.1016/S0140-6736(99)08415-9Search in Google Scholar
[9] Castle JR, Ward WK. Amperometric glucose sensors: sources of error and potential benefit of redundancy. J Diabetes Sci Technol 2010; 4: 221–225.10.1177/193229681000400127Search in Google Scholar PubMed PubMed Central
[10] Chase JG, Le Compte AJ, Suhaimi F, et al. Tight glycemic control in critical care-the leading role of insulin sensitivity and patient variability: a review and model-based analysis. Comput Methods Programs Biomed 2011; 102: 156–171.10.1016/j.cmpb.2010.11.006Search in Google Scholar PubMed
[11] Chee F, Fernando TL, Savkin AV, van Heeden V. Expert PID control system for blood glucose control in critically ill patients. IEEE Trans Inf Technol Biomed 2003; 7: 419–425.10.1109/TITB.2003.821326Search in Google Scholar
[12] Cornblath M, Schwartz R, Aynsley-Green A, Lloyd JK. Hypoglycemia in infancy: the need for a rational definition. A Ciba Foundation discussion meeting. Pediatrics 1990; 85: 834–837.10.1542/peds.85.5.834Search in Google Scholar
[13] Dickson JL, Alsweiler J, Gunn CA, Pretty CG, Chase JG. A C-Peptide-Based model of pancreatic insulin secretion in extremely preterm neonates in intensive care. J Diabetes Sci Technol 2015; 10: 111–118.10.1177/1932296815596175Search in Google Scholar PubMed PubMed Central
[14] Dickson JL, Dickson JL, Chase JG, Pretty CG, Gunn CA, Alsweiler JA. Modelling insulin clearance and degradation in very premature infants, in 9th IFAC symposium on biological and medical systems. Berlin: IFAC Papers Online 2015.10.1016/j.ifacol.2015.10.107Search in Google Scholar
[15] Dickson JL, Hewett JN, Gunn CA, Lynn A, Shaw GM, Chase JG. On the problem of patient-specific endogenous glucose production in neonates on stochastic targeted glycemic control. J Diabetes Sci Technol 2013; 7: 913–927.10.1177/193229681300700414Search in Google Scholar PubMed PubMed Central
[16] Dickson JL, Le Comptea AJ, Floyda RP, Geoffrey Chasea J, Lynnb A, Shawc GM. Development and optimisation of stochastic targeted (STAR) glycaemic control for pre-term infants in neonatal intensive care. Biomed Signal Process Control 2013; 8: 215–221.10.1016/j.bspc.2012.08.002Search in Google Scholar
[17] Evans A, Shaw GM, Le Compte A, et al. Pilot proof of concept clinical trials of Stochastic Targeted (STAR) glycemic control. Ann Intensive Care 2011; 1: 38.10.1186/2110-5820-1-38Search in Google Scholar PubMed PubMed Central
[18] Facchinetti A, Del Favero S, Sparacino G, Castle JR, Ward WK, Cobelli C. Modeling the glucose sensor error. IEEE Trans Biomed Eng 2014; 61: 620–629.10.1109/TBME.2013.2284023Search in Google Scholar PubMed
[19] Fisk L, Le Compte AJ, Shaw GM, Penning S, Desaive T, Chase JG. STAR Development and Protocol Comparison. IEEE Trans Biomed Eng 2012; 59: 3357–3364.10.1109/TBME.2012.2214384Search in Google Scholar PubMed
[20] Hall NJ, Peters M, Eaton S, Pierro A. Hyperglycemia is associated with increased morbidity and mortality rates in neonates with necrotizing enterocolitis. J Pediatr Surg 2004; 39: 898–901.10.1016/j.jpedsurg.2004.02.005Search in Google Scholar PubMed
[21] Hann CE, Chase JG, Lin J, Lotz T, Doran CV, Shaw GM. Integral-based parameter identification for long-term dynamic verification of a glucose-insulin system model. Comput Methods Programs Biomed 2005; 77: 259–270.10.1016/j.cmpb.2004.10.006Search in Google Scholar
[22] Harris DL, Weston PJ, Signal M, Chase JG, Harding JE. Dextrose gel for neonatal hypoglycaemia (the Sugar Babies Study): a randomised, double-blind, placebo-controlled trial. Lancet 2013; 382: 2077–2083.10.1016/S0140-6736(13)61645-1Search in Google Scholar
[23] Hays SP, Smith B, Sunehag AL. Hyperglycemia is a risk factor for early death and morbidity in extremely low birth-weight infants. Pediatrics. 2006; 118: 1811–1818.10.1542/peds.2006-0628Search in Google Scholar PubMed
[24] Heimann K, Peschgens T, Kwiecien R, Stanzel S, Hoernchen H, Merz U. Are recurrent hyperglycemic episodes and median blood glucose level a prognostic factor for increased morbidity and mortality in premature infants </=1500 g? J Perinat Med 2007; 35: 245–248.10.1515/JPM.2007.057Search in Google Scholar PubMed
[25] Hey E. Hyperglycaemia and the very preterm baby. Semin Fetal Neonatal Med 2005; 10: 377–387.10.1016/j.siny.2005.04.008Search in Google Scholar PubMed
[26] Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 2003; 78: 1471–1478.10.4065/78.12.1471Search in Google Scholar PubMed
[27] Le Compte AJ, Lee DS, Chase JG, Lin J, Lynn A, Shaw GM. Blood glucose prediction using stochastic modeling in neonatal intensive care. IEEE Trans Biomed Eng 2010; 57: 509–518.10.1109/TBME.2009.2035517Search in Google Scholar PubMed
[28] Le Compte AJ, Lynn AM, Lin J, Pretty CG, Shaw GM, Chase JG. Pilot study of a model-based approach to blood glucose control in very-low-birthweight neonates. BMC Pediatr 2012; 12: 117.10.1186/1471-2431-12-117Search in Google Scholar PubMed PubMed Central
[29] Lin J, Lee D, Chase JG, et al. Stochastic modelling of insulin sensitivity and adaptive glycemic control for critical care. Comput Methods Programs Biomed 2008; 89: 141–152.10.1016/j.cmpb.2007.04.006Search in Google Scholar PubMed
[30] Lucas A, Morley R, Cole TJ. Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia. Brit Med J 1988; 297: 1304–1308.10.1136/bmj.297.6659.1304Search in Google Scholar PubMed PubMed Central
[31] Ostertag S, Jovanovic L, Lewis B, Auld PA. Insulin pump therapy in the very low birth weight infant. Pediatrics. 1986; 78: 625–630.10.1542/peds.78.4.625Search in Google Scholar
[32] Penning S, Chase JG, Preiser JC, et al. Does the achievement of an intermediate glycemic target reduce organ failure and mortality? A post hoc analysis of the Glucontrol trial. J Crit Care 2014; 29: 374–379.10.1016/j.jcrc.2014.01.013Search in Google Scholar
[33] Sexson WR. Incidence of neonatal hypoglycemia: a matter of definition. J Pediatr 1984; 105: 149–150.10.1016/S0022-3476(84)80382-0Search in Google Scholar
[34] Signal M, Le Compte A, Shaw GM, Chase JG. Glycemic levels in critically ill patients: are normoglycemia and low variability associated with improved outcomes? J Diabetes Sci Technol 2012; 6: 1030–1037.10.1177/193229681200600506Search in Google Scholar
[35] Thabet F, Bourgeois J, Guy B, Putet G. Continuous insulin infusion in hyperglycaemic very-low-birth-weight infants receiving parenteral nutrition. Clin Nutr 2003; 22: 545–547.10.1016/S0261-5614(03)00056-6Search in Google Scholar
©2017 Walter de Gruyter GmbH, Berlin/Boston
